Innovating CBT-I for Cancer Survivors: An Optimization Trial
Massachusetts General Hospital
80 participants
Sep 6, 2024
INTERVENTIONAL
Conditions
Summary
The overall goal of this project is to conduct a factorial, randomized controlled trial to optimize synchronous, virtual delivery of CBT-I for cancer survivors. The proposed project will yield multiple deliverables to innovate cancer survivorship care, chiefly an optimized, scalable, virtually-delivered intervention that addresses chronic insomnia, one of the most deleterious concerns among the growing demographic of cancer survivors in the U.S. Findings will inform future considerations for delivering CBT-I to cancer survivors.
Eligibility
Inclusion Criteria4
- History of nonmetastatic, localized, or regional solid or blood malignancy(ies)
- Completion of primary cancer treatment (radiation, surgery, and/or chemotherapy). Use of hormonal, maintenance, oral, and immunotherapies is permitted.
- Chronic insomnia (DSM-5 criteria)
- years of age or older
Exclusion Criteria4
- Self-reported inability to speak and write in English
- Undertreated noninsomnia sleep disorder (e.g., sleep apnea)
- Undertreated epilepsy, undertreated serious mental illness, undertreated suicidality, and/or psychiatric hospitalization in the past year
- Unwilling or unable to discontinue night shift work
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
4 weekly SSP sessions delivered to individual participants (session durations approximately 45 min/session). No booster sessions.
4 weekly SSP sessions delivered to groups of participants (session durations approximately 90 min/session). No booster sessions.
4 weekly SSP sessions delivered to individual participants (session durations approximately 45 min/session). 3 monthly booster sessions.
4 weekly SSP sessions delivered to groups of participants (session durations approximately 90 min/session). 3 monthly booster sessions.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06181643